This event has no dates available for booking. Please contact the event organiser.

SYDNEY - Medical Cannabis Health Professionals 2.0


                                    
Medicinal cannabis was legalised in Australia in November 2016. The global legal cannabis market is expected to grow to over US$20 billion by 2020. There is good clinical evidence that it may be of benefit in Chronic Pain, MS, Nausea in Cancer Related Chemotherapy and Drug Resistant Epilepsy.
Come and learn about the latest trends and scientific research in this exciting new field from a range of experts.

Medicinal cannabis was legalised in Australia in November 2016. The global legal cannabis market is expected to grow to over US$20 billion by 2020.

There is good clinical evidence that it may be of benefit in chronic pain, MS, nausea in cancer related chemotherapy and drug resistant epilepsy.

Come and learn about the latest trends and scientific research in this exciting new field from a range of experts.
 

PRESENTERS INCLUDE

Paul Mavor - Health House International
Paul is a pharmacist who has been researching the potential of medicinal cannabis as a treatment for several years. His company was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Paul brings a wealth of knowledge from his hands-on research in the U.S., Canada and Israel. www.healthhouse.com.au

Justin Sinclair – TMC Consultancy Justin is a Research Fellow at NICM, an international leader in integrative medicine research based at Western Sydney University where he is also the co-ordinator of the Australian Medicinal Cannabis Research & Education Collaboration. For almost 3 years he has also served on United in Compassion’s Scientific Advisory Board, Australia’s leading medicinal cannabis patient advocacy group, in a pro bono capacity. His scientific background is in pharmacognosy (i.e. drugs that come from plants), but his research interests extend into botany, ethnopharmacology and analytical phytochemistry. He is currently a co-investigator on several clinical research projects in development around medicinal cannabis and has published on the topics of cannabis and the endocannabinoid system, pain management and herb/drug interactions in peer reviewed publications. He is a member of the Society of Cannabis Clinicians and International Cannabinoid Research Society. www.tmconsultancy.com.au

Doctor Teresa Towpik - General Practitioner
Teresa is a Polish born doctor currently practicing in Katoomba NSW. As a GP for more than 30 years, Dr Towpik has prescribed thousands of drugs for patients, many of them opioids which can have severe side effects. Her research into cannabis has led her to believe it could be a much better form of pain relief. She is a cancer survivor and passionate about using medical cannabis as a treatment option. www.medihuanna.com

Doctor Alex Wodak
Alex serves as a Physician and the Director of the Alcohol and Drug Service, at St Vincent’s Hospital in Sydney, Australia. Dr. Wodak serves as Member of Medical Advisory Board at AusCann Group Holdings Ltd. He is a notable advocate of drug reform laws and helped establish the National Drug and Alcohol Research Centre, the NSW Users AIDS Association and the Australian Society of HIV Medicine. He is President of the Australian Drug Law Reform Foundation and was President of the International Harm Reduction Association.

Professor Iain McGregor - Academic Director at The Lambert Initiative (Sydney University)

Iain is the Academic Director of the Lambert Initiative and an NHMRC Principal Research Fellow. He is responsible for academic and organisational leadership, strategic direction, governance and reporting, and the development and achievement of the preclinical and clinical research strategies. Iain oversees a team of more than 25 staff and students, including the Associate Directors, and reports to the Lambert Initiative Internal Management Group (IMG). Renowned in the field of medicinal cannabis research, Iain leads stakeholder relations, advocacy and education. www.sydney.edu.au/lambert/

Cameron Scadding - Source Certain
Cameron is an analytical chemist and an expert in supply chain integrity and ensuring that consumers get what is both promised and from the source claimed. www.sourcecertain.com

Rhys Cohen – Senior Project Officer at The Lambert Initiative (Sydney University)
Rhys acts as a key interface between the Lambert Initiative for Cannabinoid Therapeutics and government, regulators, industry and consumers.He responsible for leading a variety of projects within the Lambert Initiative to do with drug policy; the scheduling and rescheduling of cannabis products; NSW Health and TGA/ODC licensing; industry engagement; consumer outreach; and education. He is also responsible for the development of public policy positions for the Lambert Initiative relating to issues such as patient access. www.sydney.edu.au/lambert/

Ben Oakley- Patient Advocate
Ben is one of only 20 people in Australia suffering from ’Stiff Person Syndrome‘. He will explain his journey and his fight to access medicinal cannabis. www.chuffed.org/project/drop-a-dollar

 

Location

Uni of Sydney - Veterinary Science Conference Centre 208 Webster
Regimental Drive, Sydney, NSW 2000

Contact Details



A not for profit dedicated to lobbying, education and research in medicinal cannabis

Map
Contact Form

This event is currently closed and no contact details are available